Sarah Morgan

2.5k total citations
38 papers, 1.1k citations indexed

About

Sarah Morgan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Sarah Morgan has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 10 papers in Cognitive Neuroscience. Recurrent topics in Sarah Morgan's work include Hemispheric Asymmetry in Neuroscience (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Sarah Morgan is often cited by papers focused on Hemispheric Asymmetry in Neuroscience (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Sarah Morgan collaborates with scholars based in Germany, United Kingdom and United States. Sarah Morgan's co-authors include Joseph P. Huston, Richard W. Orrell, J.P. Huston, Heinz Steiner, Rainer K.W. Schwarting, Katja Hofele, Georg Auburger, Monika Pritzel, Hans-Theo Weiler and Martin Sarter and has published in prestigious journals such as Brain, Neuroscience and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Sarah Morgan

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Morgan Germany 20 515 428 271 202 157 38 1.1k
Giovanna Levandis Italy 21 643 1.2× 510 1.2× 261 1.0× 217 1.1× 55 0.4× 28 1.2k
Katéri Brisebois Canada 7 482 0.9× 379 0.9× 361 1.3× 136 0.7× 142 0.9× 8 1.1k
Kazuhiro Niizato Japan 19 372 0.7× 462 1.1× 433 1.6× 149 0.7× 150 1.0× 57 1.2k
Alissa L. Nana United States 16 544 1.1× 310 0.7× 421 1.6× 149 0.7× 105 0.7× 27 1.1k
K Krampfl Germany 16 826 1.6× 400 0.9× 384 1.4× 183 0.9× 124 0.8× 32 1.3k
Doris Tomas Australia 16 408 0.8× 395 0.9× 293 1.1× 152 0.8× 74 0.5× 30 923
Rosa Luisa Potenza Italy 21 357 0.7× 699 1.6× 455 1.7× 199 1.0× 84 0.5× 38 1.2k
Elsa Diguet France 17 534 1.0× 795 1.9× 650 2.4× 235 1.2× 58 0.4× 20 1.3k
Antonella Borreca Italy 17 242 0.5× 313 0.7× 562 2.1× 233 1.2× 71 0.5× 32 1.2k
Yun Ha Jeong South Korea 15 423 0.8× 248 0.6× 444 1.6× 258 1.3× 64 0.4× 24 1.3k

Countries citing papers authored by Sarah Morgan

Since Specialization
Citations

This map shows the geographic impact of Sarah Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Morgan more than expected).

Fields of papers citing papers by Sarah Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Morgan. The network helps show where Sarah Morgan may publish in the future.

Co-authorship network of co-authors of Sarah Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Morgan. A scholar is included among the top collaborators of Sarah Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Morgan. Sarah Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calcagno, Narghes, Sarah Morgan, Neehar D. Parikh, et al.. (2025). Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States. European Journal of Neurology. 32(9). e70360–e70360.
2.
Castanho, Isabel, Pourya Naderi Yeganeh, Carles A. Boix, et al.. (2025). Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheimer’s disease. Molecular Neurodegeneration. 20(1). 103–103.
3.
Yeganeh, Pourya Naderi, Dimitra Karagkouni, Yered Pita-Juárez, et al.. (2023). PanomiR: a systems biology framework for analysis of multi-pathway targeting by miRNAs. Briefings in Bioinformatics. 24(6). 2 indexed citations
4.
Prokopenko, Dmitry, Sanghun Lee, Julian Hecker, et al.. (2022). Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2. Molecular Psychiatry. 27(4). 1963–1969. 16 indexed citations
5.
Morgan, Sarah, et al.. (2022). Oropharyngeal Dysphagia in Acute Cervical Spinal Cord Injury: A Literature Review. Dysphagia. 38(4). 1025–1038. 16 indexed citations
6.
Morgan, Sarah, Pourya Naderi Yeganeh, Yered Pita-Juárez, et al.. (2022). Most Pathways Can Be Related to the Pathogenesis of Alzheimer’s Disease. Frontiers in Aging Neuroscience. 14. 846902–846902. 24 indexed citations
7.
Iacoangeli, Alfredo, Ahmad Al Khleifat, William Sproviero, et al.. (2019). DNAscan: personal computer compatible NGS analysis, annotation and visualisation. BMC Bioinformatics. 20(1). 213–213. 14 indexed citations
8.
Mehta, Puja R., Ashley Jones, Sarah Opie-Martin, et al.. (2018). Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias. Journal of Neurology Neurosurgery & Psychiatry. 90(3). 268–271. 29 indexed citations
9.
Ellison, Stuart, Antonio Trabalza, Veronica Tisato, et al.. (2013). Dose-dependent Neuroprotection of VEGF165 in Huntington's Disease Striatum. Molecular Therapy. 21(10). 1862–1875. 19 indexed citations
10.
Morgan, Sarah & Joseph E. Baggott. (2006). Medical Foods: Products for the Management of Chronic Diseases. Nutrition Reviews. 64(11). 495–501.
11.
Morgan, Sarah & Joseph E. Baggott. (2006). Medical Foods: Products for the Management of Chronic Diseases. Nutrition Reviews. 64(11). 495–501. 15 indexed citations
12.
Hofele, Katja, et al.. (2001). Evidence for a Dissociation between MPTP Toxicity and Tyrosinase Activity Based on Congenic Mouse Strain Susceptibility. Experimental Neurology. 168(1). 116–122. 27 indexed citations
13.
Hofele, Katja, et al.. (2000). Evidence for resistance to MPTP in C57BL/6 × BALA/c F1 hybrids as compared with their progenitor strains. Neuroreport. 11(5). 1093–1096. 24 indexed citations
14.
Morgan, Sarah, George G. Nomikos, & J.P. Huston. (1993). Behavioral analysis of asymmetries induced by unilateral 6-OHDA injections into the substantia nigra. Behavioral and Neural Biology. 60(3). 241–250. 14 indexed citations
15.
Morgan, Sarah, Joseph E. Baggott, & G S Alarcón. (1993). Methotrexate and sulfasalazine combination therapy: Is it worth the risk?. Arthritis & Rheumatism. 36(2). 281–282. 7 indexed citations
16.
17.
Morgan, Sarah & J.P. Huston. (1990). The interhemispheric projection from the substantia nigra to the caudate-putamen as depicted by the anterograde transport of [3H]leucine. Behavioural Brain Research. 38(2). 155–162. 19 indexed citations
18.
Morgan, Sarah, et al.. (1986). Dissociation of crossed and uncrossed nigrostriatal projections with respect to site of origin in the rat. Neuroscience. 17(3). 609–614. 24 indexed citations
19.
Pritzel, Monika, Martin Sarter, Sarah Morgan, & Joseph P. Huston. (1983). Interhemispheric nigrostriatal projections in the rat: Bifurcating nigral projections and loci of crossing in the diencephalon. Brain Research Bulletin. 10(3). 385–390. 53 indexed citations
20.
Morgan, Sarah, Joseph P. Huston, & Monika Pritzel. (1983). Effects of reducing sensory-motor feedback on the appearance of crossed nigro-thalamic projections and recovery from turning induced by unilateral substantia nigra lesions. Brain Research Bulletin. 11(6). 721–727. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026